Literature DB >> 19035519

Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis.

Caroline Ospelt1, Fabia Brentano, Yvonne Rengel, Joanna Stanczyk, Christoph Kolling, Paul P Tak, Renate E Gay, Steffen Gay, Diego Kyburz.   

Abstract

OBJECTIVE: To analyze the expression, regulation, and biologic relevance of Toll-like receptors (TLRs) 1-10 in synovial and skin fibroblasts and to determine the expression levels of TLRs 2, 3, and 4 in synovial tissues from patients with early rheumatoid arthritis (RA), longstanding RA, and osteoarthritis (OA).
METHODS: Expression of TLRs 1-10 in RA synovial fibroblasts (RASFs), OASFs, and skin fibroblasts was analyzed by real-time polymerase chain reaction (PCR). Fibroblasts were stimulated with tumor necrosis factor alpha, interleukin-1beta (IL-1beta), bacterial lipopeptide, poly(I-C), lipopolysaccharide, and flagellin. Production of IL-6 was determined by enzyme-linked immunosorbent assay and induction of TLRs 2-5, matrix metalloproteinases (MMPs) 3 and 13 messenger RNA by real-time PCR. Expression of TLRs 2-4 in synovial tissues was analyzed by immunohistochemistry.
RESULTS: Synovial fibroblasts expressed TLRs 1-6, but not TLRs 7-10. Among the expressed TLRs, TLR-3 and TLR-4 were the most abundant in synovial fibroblasts, and stimulation of synovial fibroblasts with the TLR-3 ligand poly(I-C) led to the most pronounced increase in IL-6, MMP-3, and MMP-13. In contrast, skin fibroblasts did not up-regulate MMP-3 or MMP-13 after stimulation with any of the tested stimuli. In synovial tissues from patients with early RA, TLR-3 and TLR-4 were highly expressed and were comparable to the levels of patients with longstanding RA. These expression levels were elevated as compared with those in OA.
CONCLUSION: Our findings of high expression of TLRs, particularly TLRs 3 and 4, at an early stage of RA and the reactivity of synovial fibroblasts in vitro to TLR ligands suggest that TLR signaling pathways resulting in persistent inflammation and joint destruction are activated early in the disease process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19035519     DOI: 10.1002/art.24140

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  128 in total

1.  TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-α levels.

Authors:  Nathan D Chamberlain; Olga M Vila; Michael V Volin; Suncica Volkov; Richard M Pope; William Swedler; Arthur M Mandelin; Shiva Shahrara
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

2.  Membrane-bound toll-like receptors are overexpressed in peripheral blood and synovial fluid mononuclear cells of enthesitis-related arthritis category of juvenile idiopathic arthritis (JIA–ERA) patients and lead to secretion of inflammatory mediators.

Authors:  Arpita Myles; Mujeeb T Rahman; Amita Aggarwal
Journal:  J Clin Immunol       Date:  2012-06       Impact factor: 8.317

Review 3.  Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis.

Authors:  QiQuan Huang; Richard M Pope
Journal:  J Leukoc Biol       Date:  2010-05-19       Impact factor: 4.962

Review 4.  Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis.

Authors:  Jamie Campbell; David Lowe; Matthew A Sleeman
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

5.  Toll-like receptor (TLR)-3: a potent driving force behind rheumatoid arthritis.

Authors:  Xiaofeng Li; Tao Xu; Yarui Wang; Cheng Huang; Jun Li
Journal:  Clin Rheumatol       Date:  2013-11-21       Impact factor: 2.980

6.  Distinct ON/OFF fluorescence signals from dual-responsive activatable nanoprobes allows detection of inflammation with improved contrast.

Authors:  Mathieu L Viger; Guillaume Collet; Jacques Lux; Viet Anh Nguyen Huu; Monica Guma; Alexandra Foucault-Collet; Jason Olejniczak; Shivanjali Joshi-Barr; Gary S Firestein; Adah Almutairi
Journal:  Biomaterials       Date:  2017-03-28       Impact factor: 12.479

7.  Toll-like receptor-4 signaling: a new potential therapeutic pathway for rheumatoid arthritis.

Authors:  Xiaofeng Li; Tao Xu; Yarui Wang; Cheng Huang; Jun Li
Journal:  Rheumatol Int       Date:  2014-02-20       Impact factor: 2.631

Review 8.  The role of glycoprotein 96 in the persistent inflammation of rheumatoid arthritis.

Authors:  Qi-Quan Huang; Richard M Pope
Journal:  Arch Biochem Biophys       Date:  2012-12-17       Impact factor: 4.013

Review 9.  The role of toll-like receptors in rheumatoid arthritis.

Authors:  Qi-Quan Huang; Richard M Pope
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

10.  Local interleukin-1-driven joint pathology is dependent on toll-like receptor 4 activation.

Authors:  Shahla Abdollahi-Roodsaz; Leo A B Joosten; Marije I Koenders; Ben T van den Brand; Fons A J van de Loo; Wim B van den Berg
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.